Pacific RxTracts - July 2026

Authors

• Pacific RxTracts

Files

Description

Articles:

• Tribute: In Memory of Evan Le
• Redefining Influenza Prevention: Phase 3 Trial of an mRNA Influenza Vaccine
• Risk of Non-Vitamin K Anticoagulants in Atrial Fibrillation
• Oral Semaglutide and Cardiovascular Risk: Expanding Its Role in High-Risk Patients
• Baxdrostat for Resistant Hypertension: The Bax24 Phase 3 Trial
• SGLT2 Inhibitors Shown to Normalize Blood Pressure in Patients with Type 2 Diabetes
• Brolucizumab: A New Vision for Treating Proliferative Diabetic Retinopathy
• Mavacamten Comes of Age: FDA Expands Treatment Options for Adolescent Hypertrophic Cardiomyopathy
• Children and Adolescent CKD Management: New Evidence Supports RAAS Inhibitors as First-Line Therapy
• Comparing Survival Outcomes of CDK4/6 Inhibitors plus Endocrine Therapy vs. Endocrine Monotherapy in HR+, HER2- Advanced Breast Cancer
• Double Duty: PCSK9 Inhibitors as Adjuncts to Immune Checkpoint Inhibitors
• Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer
• Daraxonrasib Given Expanded Access by FDA for Metastatic Pancreatic Ductal Adenocarcinoma
• Bulevirtide-gmod for First Treatment of Chronic Hepatitis D Virus
• Novel Botanical Moisturizer Improves Rosacea Outcomes Compared to Metronidazole
• A Phase 3 Trial of Brepocitinib in Dermatomyositis
• ORATORIO-HAND Trial Expands Evidence for Ocrelizumab in PPMS

Publication Date

7-16-2026

Volume

23

Issue

8

Pages

10

Publisher

University of the Pacific

City

Stockton, CA

Disciplines

Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences

Recommended Citation

Pacific RxTracts, "Pacific RxTracts - July 2026" (2026). Pacific RxTracts. 17.
https://scholarlycommons.pacific.edu/rx-tracts/17